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The fine needle aspiration (FNA) of cells infiltrating renal
allografts has proven to be a useful and safe tool for monitoring
renal graft outcome [1]. The recent availability of broad panels
of murine monoclonal antibodies defining lymphocyte subsets
has permitted the fine characterization of the profile of the FNA
cell membrane. Thus, it has been shown that the onset of graft
rejection is associated, in some cases, with the presence of large
proportions of infiltrating cells that express the membrane
antigen characteristic of suppressor cytotoxic lymphocytes
(that is, OKT8 cells) [2, 31. It remains to be shown, however,
whether these cells possess the functional capacities cone-
sponding to this phenotype. Until now, this has been impossible
due to the small number of cells recovered from FNA samples.
The aim of this brief report is to describe a technique which
allows the in vitro expansion of the lymphoid cell population
contained in FNA samples in long-term cultures and thus the
simultaneous analysis of their phenotypes and functions.
Methods. Fine needle aspiration samples were obtained from
six renal allograft recipients undergoing rejection. In all the
patients the FNA was performed before the onset of anti-
rejection treatment (that is, high dose corticotherapy). Freshly
collected FNA samples were analyzed in parallel with blood
samples drawn at the same moment from the same patients. In
the present study only the aspirates containing high proportions
of blastic mononuclear cells that were absent from peripheral
blood were considered.
Hemolysis of the red cells contaminating the cell samples was
performed using the following .buffer: 8.29 g NH4C1, 37 mg
disodium EDTA, and I g KHCO3 per liter, pH 7.3. Leukocytes
were washed and recovered following a 10-mm centrifugation at
1500 rpm. The viable cells were counted by trypan blue dye
exclusion, and cultured in round-bottomed microplates
(Nunclon, Roskild, Sweden) (1 x iO to 2 x l0 cells per
microwell in 0.2 ml). The number of cells recovered from FNA
samples usually ranged from 5 x iO to 15 x i04 cells,
depending on the patient. The conditioned medium (CM) used
for culture was RPMI 1640 (GIBCO, Paisley, United Kingdom)
supplemented with antibiotics, 50% crude supernatant contain-
ing significant levels of interleukin-2 (IL-2), 10% heat-
inactivated, fetal calf serum (FCS) (GIBCO, Paisley, United
Kingdom), 5 x l0- M mercaptoethanol and l%glutamine. The
IL-2 containing supernatant was produced by stimulating nor-
mal human peripheral blood lymphocytes with phytohemag-
glutinin A (DIFCO, Detroit, Michigan, USA) for 48 hr as
previously described [4]. The supernatants used to grow FNA
cells contained approximately 0.7 to I U/ml of IL-2 activity
(assessed by CTLL2 proliferation, see [5] for the definition of
an IL-2 unit). After the initial 4 days of culture, the cells were
fed every 48 to 72 hr by replacing half of the culture medium
with fresh CM. Cell proliferation was regularly evaluated by
means of cell counting with trypan blue dye, in parallel with
3H-thymidine incorporation. This latter method was particu-
larly useful for the assessment of proliferation during the early
days of culture. By day 4 of the culture, the FNA cells from all
patients began to incorporate significant amounts of
3H-thymidine: patient 1: day 4,4177 cpm; day 5, 9042 cpm; day
6, 19335; patient 2: day 3, 548 cpm; day 4, 2353 cpm; day 5,
16506 cpm. Moreover, by days 7 to 11, depending on the
patient, and approximately until day 20, the growth rate in-
creased significantly with a doubling time of 6 hr (assessed by
cell counting). Thereafter, the proliferation decreased with a
doubling time close to 12 hr. All cultures were successfully
maintained for 30 to 45 days.
Phenotypic analysis of cultured cells was performed at regu-
lar intervals by means of an indirect immunofluorescence
microtest, described by Cashman et al [6], using the OKT series
of monoclonal antibodies. The antibodies used were OKT3
(IgG2a), OKT4 (IgG2b), and OKT8 (IgG2a) which react, re-
spectively, with mature peripheral human T cells,
helper/inducer T cells and suppressor/cytotoxic T cells [7]. In
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a The values reported correspond to the cell count performed in each
patient before doing the labeling experiments. When considering each
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amount of cells recovered/patient at the different times.
addition, OKIA (IgG2) specific for membrane molecules coded
by the DR locus which have been shown to be significantly
expressed on "activated" T cells [8] and OKT9 that recognizes
the transferrin receptor [9] were used.
Double indirect immunofluorescence labelings were per-
formed to assess the presence of OKT418 cells, using fluo-
rescein and rhodamine-labeled anti-mouse isotype sera (Nor-
dic, Tilburg, The Netherlands).
Results and discussion. The results obtained are detailed in
Tables 1, 2, and 3. By day 10 of the culture, most cells from all
patients studied expressed the OKT3-defined antigen (Table 1).
Importantly, the expression of this marker, that is, character-
istic of mature T cells, remained almost constant throughout the
entire culture period (30 to 45 days). In all cases, the proportion
of OKT4 cells progressively decreased during the culture
period and totally disappeared by day 30 in two patients. The
opposite pattern was observed for OKT8 cells, although with
40[
No. effector cells/target cell
Fig. 1. Nonspec{fic cytolytic activity expressed by IL-2 -expanded fine
needle aspiration cells from two renal transplant patients. The cells
were tested on day 28 of culture. Their lytic capacities against two
human cell lines, LHNI3 (•) and K562 (), were tested. The target
cells were labeled with 5tCr (sodium, chromate, NEN, Boston, Mas-
sachusetts, USA) for 1 hr at 37°C (100 tCi of 51Cr for 1.6 x 10 cells in
250 pi), washed three times and resuspended at io cells/mi in RPMI
1640 containing 10% FCS and 1% glutamine. One hundred microliters
of the suspension were deposited into round-bottomed microwells and
varied proportions of effector cells (100 1.d) were added in triplicate. The
trays were centrifuged and incubated for 5 hr at 37°C. One hundred
microliters of supernatant were recovered from each well and the 51Cr
release was measured. The cytolytic index was calculated as follows:
cpm test — cpm
spont>< 100
cpm max — cpm spont
where cpm max is the maximal release (target cells incubated with
detergent) and cpm spont is the spontaneous release (target cells
incubated without effector cells).
slight kinetic variations depending on the patient. There was,
however, a clear overall tendency toward an increase in the
proportions of these OKT8 lymphocytes. It is interesting to
note the appearance of doubly labeled OKT48 cells in four
patients. This particular phenotype is characteristic of normal
human thymocytes and has been observed on peripheral lym-
phocytes in some pathological situations [10], as well as in renal
allograft recipients [11]. High proportions of T cells expressing
the OKIA phenotype were detected in all patients, mainly by
days 15 to 20 of culture (Table 2). Using an indirect method
(described in Table 3 and [10]), it could be deduced that most
OKIA cells belonged to the OKT8 cell pooi (and not to the
OKT4 one); thus, the culture system used favors the expan-
sion of activated T lymphocytes expressing the cytotox-
ic/suppressor phenotype.
Cells from two patients were tested on day 28 of the culture
for their capacity to lyse LHNI3, an HLA, EVBB cell line;
and the HLA, NK-sensitive K562 cell line. As shown in
Figure 1, for both patients the cultured cells exhibited a
significant lytic activity against the two cell lines.
Studies are now in progress to clone the expanded cells
recovered from FNA samples to further explore their cytolytic
capacity against nonspecific as well as donor-specific targets.
Although they are incomplete and preliminary, it seems
important to present these few results that clearly indicate that
the immunological technology used in this study may be applied
to the serial analysis of FNA samples and thus will probably
promote new insights into the intricate mechanisms mediating
cellular-induced renal allograft rejection.
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Table 2. Proportion of cells expressing the OKIA and the OKT9 defined marker among IL-2-expanded fine needle aspiration cells from six
renal allograft recipients
Days ofculture
Patient no. 10 14 25 28
1
OKIA
—
OKT9
—
OKIA'
84%
OKT9
2%
OKIA
63%
OKT9
3%
OKlA
75%
OKT9
22%
2 59% 40% 53% 37% 17% 3% 55% 7%
3 52% 14% 81% 8% 79% 12% 61% 0%
4 58% 6% 77% 7% 72% 10% 53% 10%
5 — — 45% 15% 22% 0% 42% 1%
6 87% 17% 55% 21% 16% 1% 37% 1%
Table 3. Increasing proportions of cells expressing the association of the OKIA and OKT8 defined antigens during the culture period
Day of culture
Patient no.
14
1 3
18
1 3
25
1 3
28
1 3
% OKI 84 77 80 72 63 72 75 53
% (OKI + OKT4) 85 80 78 72 58 80 77 60
% (OKI + OKT8y' 61 81 83 78 96 99 92 72
Deduced % OKIA+4*C 42 63 27 32 28 10 0 8
Deduced % OKIA8 84 78 56 79 57 48 73 46
a Percentage values of fluorescent cells labeled by the OKIA and OKT4 monoclonal antibodies used in combination are shown.
b Percentage values of fluorescent cells labeled by the OKIA and OKT8 monoclonal antibodies used in combination are shown.
In each case, the proportion of doubly labeled cells (either OKIA4or OKIA8) is deduced as follows:
% OKI4 =1%OKI+ % OKT4/— % (0K14 + OKT4Y
% OKI48 =1% OKI + % OKT8I— % (OKI + OKT8)
that is by subtracting the percentage value obtained when the two antibodies were mixed together in the same tube from the sum of the
percentage values observed when the two antibodies were used separately. In fact, when doubly labeled cells were present, the number of
fluorescent cells counted with the two antibodies together was lower than the sum of the values encountered with the use of the two antibodies
individually.
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